Open prospective trial an 6-thioguanine for chronic active Crohn's disease

被引：0
|
作者：
Herrlinger, KR
Kreisel, W
Schwab, M
Fischer, C
Schölmerich, J
Fleig, WE
Rühl, A
Reinshagen, M
Metzler, J
Fellermann, K
Stange, EF
机构：
来源：
GASTROENTEROLOGY | 2002年 / 122卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
T1203
引用
收藏
页码：A432 / A432
页数：1
相关论文
共 50 条
  • [1] 6-thioguanine maintains remission in chronic active Crohn's disease
    Herrlinger, KR
    Kreisel, W
    Deibert, P
    Schwab, M
    Fellermann, K
    Stange, EF
    GASTROENTEROLOGY, 2003, 124 (04) : A519 - A519
  • [2] 6-Thioguanine - efficacy and safety in chronic active Crohn's disease
    Herrlinger, KR
    Kreisel, W
    Schwab, M
    Schoelmerich, J
    Fleig, WE
    Ruhl, A
    Reinshagen, M
    Deibert, P
    Fellermann, K
    Greinwald, R
    Stange, EF
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (04) : 503 - 508
  • [3] High variation of 6-thioguanine absorption in patients with chronic active Crohn's disease
    Deibert, P
    Dilger, K
    Hofmann, U
    Nauck, S
    Stoelben, S
    Kreisel, W
    GASTROENTEROLOGY, 2003, 124 (04) : A522 - A523
  • [4] Hepatotoxicity associated with 6-thioguanine therapy for Crohn's disease
    Rulyak, SJ
    Saunders, MD
    Lee, SD
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 36 (03) : 234 - 237
  • [5] 6-thioguanine therapy in Crohn's disease - A Swedish experience
    Almer, Sven H.
    Hjortswang, Henrik
    Peterson, Curt
    Hindorf, Ulf
    GASTROENTEROLOGY, 2007, 132 (04) : A185 - A185
  • [6] Efficacy of 6-thioguanine in patients with Crohn's disease intolerant to azathioprine
    Ivastinovic, D
    Hoegenauer, C
    Petritsch, W
    Wenzl, HH
    Hinterleitner, TA
    GASTROENTEROLOGY, 2004, 126 (04) : A630 - A631
  • [7] Further Experience with the Use of 6-Thioguanine in Patients with Crohn's Disease
    Ansari, Azhar
    Elliot, Tim
    Fong, Farina
    Arenas-Hernandez, Monica
    Rottenberg, Giles
    Portmann, Bernard
    Lucas, Sebastian
    Marinaki, Anthony
    Sanderson, Jeremy
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (10) : 1399 - 1405
  • [8] A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis
    Teml, A
    Schwab, M
    Harrer, M
    Miehsler, W
    Schaeffeler, E
    Dejaco, C
    Mantl, M
    Schneider, B
    Vogelsang, H
    Reinisch, W
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2005, 40 (10) : 1205 - 1213
  • [9] 6-Thioguanine therapy in Crohn's disease-Observational data in Swedish patients
    Almer, S. H. C.
    Hjortswang, H.
    Hindorf, U.
    DIGESTIVE AND LIVER DISEASE, 2009, 41 (03) : 194 - 200
  • [10] Open prospective study on 6-thioguanine (6-TG) for Crohn's disease (CD) intolerant or resistant to azathioprine (AZA) and/or 6-mercaptopurine (6-MP)
    Harrer, M
    Schwab, M
    Teml, A
    Dejaco, C
    Mantl, M
    Vogelsang, H
    Reinisch, W
    GASTROENTEROLOGY, 2003, 124 (04) : A521 - A521
12345